Trump wants FDA to move ‘as quickly as they can’ on remdesivir coronavirus approval
President Donald Trump speaks during a Paycheck Protection Program (PPP) event in the East Room of the White House in Washington, D.C., on Tuesday, April 28, 2020.
Al Drago | Bloomberg via Getty Images
President Donald Trump said Wednesday that he wants the Food and Drug Administration to move “as quickly as they can” to approve Gilead Sciences’ antiviral drug remdesivir as a treatment for the coronavirus.
“We would like to see very quick approvals, especially with things that work,” he said at a roundtable at the White House with business executives Wednesday evening.
Earlier in the day, the FDA said it has been in “sustained and ongoing” discussions with Gilead to make remdesivir available to Covid-19 patients “as quickly as possible, as appropriate.”